FAQ ClinicalThought

Share

Program Content

Activities

  • FAQs: Targeting HER3 in NSCLC
    FAQs: Novel Antibody–Drug Conjugates and Other Agents Targeting HER3 in NSCLC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 25, 2023

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.